Generation Bio Inc. (GBIO) Social Stream



Generation Bio Inc. (GBIO): $3.39

0.14 (-3.97%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

GENERATION BIO CO (GBIO) Price Targets From Analysts

Use the tables below to see what analysts covering GENERATION BIO CO think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-12 7 $50 $35 $39.8 $1.94 1951.55%
2022-01-24 7 $31 $10 $22.8 $1.94 1075.26%
2022-02-14 7 $31 $10 $21.6 $1.94 1013.4%
2022-02-25 7 $29 $10 $20.4 $1.94 951.55%
2022-05-09 7 $29 $10 $20 $1.94 930.93%
2022-08-05 6 $29 $10 $20.2 $1.94 941.24%
2022-08-08 7 $29 $11 $19.6 $1.94 910.31%
2022-11-04 8 $25 $10 $18.6 $1.94 858.76%
2022-11-08 8 $25 $9 $17 $1.94 776.29%
2023-02-24 8 $25 $9 $14 $1.94 621.65%
2023-02-28 8 $25 $8 $13.666 $1.94 604.43%
2023-03-06 8 $25 $2.23 $12.205 $1.94 529.12%
2023-03-23 8 $25 $2.23 $11.538 $1.94 494.74%
2023-05-11 7 $25 $7 $12.333 $1.94 535.72%
2023-08-03 8 $20 $7 $11.5 $1.94 492.78%
2023-08-16 8 $20 $7 $11.666 $1.94 501.34%
2023-10-18 8 $16 $7 $11 $1.94 467.01%
2023-10-24 8 $16 $7 $11 $1.94 467.01%
2023-11-01 8 $14 $5 $9.166 $1.94 372.47%
2023-11-10 8 $14 $5 $8.833 $1.94 355.31%
2023-11-29 8 $14 $5 $8 $1.94 312.37%

The Trend in the Analyst Price Target


Over the past 28 months, GBIO's average price target has gone down $31.8.

Over the past 40 weeks, GBIO's average upside potential has been 343.68%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-06 8 25 2.23 12.205 4.13 195.52%
2023-03-24 8 25 7.00 12.333 5.08 142.78%
2023-05-11 7 25 7.00 12.333 4.58 169.28%
2023-08-03 7 20 7.00 11.500 4.49 156.12%
2023-11-29 7 14 5.00 8.000 1.16 589.66%

GBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 3 1 3 0 0 7

The Trend in the Broker Recommendations


Over the past 15 months, GBIO's average broker recommendation rating worsened by 0.41.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how GENERATION BIO CO fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 2469.86% of that group.
  • In terms of how GENERATION BIO CO fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2182.51% of that group.
  • GENERATION BIO CO's number of analysts covering the stock is greater than 2209.36% of stocks in the small market cap category.
  • In terms of how GENERATION BIO CO fares relative to Healthcare stocks, note that its average analyst price target is greater than 691.51% of that group.

Stocks similar to GENERATION BIO CO in the Pharmaceutical Products industry regarding analyst recommendations and price targets are IVA, TNGX, and IMNM.

What is the outlook for GBIO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!